Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human DOK7 Anticorps:
anti-Mouse (Murine) DOK7 Anticorps:
anti-Rat (Rattus) DOK7 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes.
Silencing DNMT3A (Montrer DNMT3A Anticorps) inhibits proliferation and invasion in ESCC cells by inducing demethylation of DOK7.
DOK7 was reduced in lung cancer and reduced DOK7 expression was associated with poorer survival.DOK7 isoform 1 plays an inhibitory role on the proliferation and migration of lung cancer cells.
Individuals with DOK7 congenital myasthenic syndrome displayed stridor and feeding difficulties at birth or progressive weakness despite normal milestones in infancy pointing to a diagnosis and should lead to neurophysiological and genetic investigation
this study demonistrated that Salbutamol is an effective treatment in patient wity congenital myasthenic syndrome due to DOK7 mutation.
DOK7 limb-girdle myasthenic syndrome can mimick congenital muscular dystrophy.
Hypermethylation of DOK7 occurs years before tumor diagnosis, suggesting a role as a powerful epigenetic blood-based biomarker as well as providing insights into breast cancer pathogenesis
In contrast to AChR deficiency due to epsilon subunit (Montrer CHRNE Anticorps) mutations, onset of DOK7 CMS (Montrer Cd2ap Anticorps) tends to be later--ages two to three years--and in DOK7 CMS (Montrer Cd2ap Anticorps) eye movements are usually spared and anticholinesterases can exacerbate the weakness
The DOK7 gene is highly polymorphic, and within these many variants, a spectrum of mutations that can underlie DOK7 Congenital myasthenic syndromes that will inform in managing this disorder, were defined.
Sequencing of DOK-7 in seronegative myasthenia gravis patients reveals no mutations.
6 CMS (Montrer Cd2ap Anticorps) patients with DOK7 mutations had congenital stridor, bilateral vocal cord palsy and difficulty with feeding
The Dok-7's C-terminal region plays a key, but not fully essential, role in MuSK (Montrer MUSK Anticorps) activation and NMJ formation.
These results demonstrate that correct, physiological levels of dok-7 expression are required for the postnatal maintenance of neuromuscular junctions.
Protein kinase CK2 (Montrer CSNK2A1 Montrer) interacts at the neuromuscular synapse with Rapsyn (Montrer RAPSN Montrer), Rac1, 14-3-3gamma (Montrer YWHAG Montrer), and Dok-7 proteins and phosphorylates the latter two.
Sp1 (Montrer SP1 Anticorps) plays a crucial role in the regulation of the dok-7 gene.
Data show a critical role for Crk (Montrer CRK Anticorps) and Crk (Montrer CRK Anticorps)-L downstream from Dok-7 in presynaptic and postsynaptic differentiation.
The crystal structure of the Dok7 PH-PTB (Montrer PTBP1 Anticorps) domains in complex with a phosphopeptide representing the Dok7-binding site on MuSK (Montrer MUSK Anticorps), is presented.
Dok-7 is essential for neuromuscular synaptogenesis through its interaction with MuSK (Montrer MUSK Anticorps)
the COOH-terminal NES (Montrer NES Anticorps) and Src (Montrer SRC Anticorps) homology 2 target motifs play key roles in Dok-7/MuSK (Montrer MUSK Anticorps) signaling for neuromuscular synaptogenesis.
The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants.
docking protein 7
, downstream of tyrosine kinase 7
, protein Dok-7
, oncoprotein induced transcript 5